C9S-50629-48909
3 vaccinations
7 coded responses
32 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 902 / CA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Cold sweat, Hyperhidrosis — Feeling: Good · Site: PainFree text: sweaty/clammy palms of hands and soles of feet, but not feeling warm overallMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
- 2021-01-12
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-20
Survey response — day 35, dose 2MedDRA: Dizziness, Hypotension — Feeling: FairFree text: hypotension, dizzy, lightheaded (have not called MD yet but will if this persists)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
-
2021-04-15
Survey response — 3 months, dose 2MedDRA: Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-15
-
2021-12-02
Dose 3 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Eye irritation, Eye pain — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Eye irritation/pain started Friday and has gotten progressively worseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Health check-in — day 7, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-16
Survey response — day 14, dose 3MedDRA: Eye pain, Rash — Feeling: FairFree text: Continued eye pain and rash.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
-
2021-12-30
Survey response — day 28, dose 3MedDRA: Rash — Feeling: GoodFree text: Most of the rash gone, but this week it suddenly appeared on the left side of my forehead.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-06
-
2022-01-13
Survey response — day 42, dose 3MedDRA: Fatigue, Headache, Heart rate increased, Rash — Feeling: Fair · Be unable to do your normal daily activitiesFree text: rash comes and goes (limited now to left side of forehead and both forearms), headaches, fatigue, increased heart rate during sleep (tracked by my watch)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): sweaty/clammy palms of hands and soles of feet, but not feeling warm overall
Release 4 — day 35, dose 2
Symptoms: hypotension, dizzy, lightheaded (have not called MD yet but will if this persists)
Release 7 — 3 months, dose 2
Symptoms: diarrhea
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Eye irritation/pain started Friday and has gotten progressively worse
Release 10 — day 14, dose 3
Symptoms: Continued eye pain and rash.
Release 10 — day 28, dose 3
Symptoms: Most of the rash gone, but this week it suddenly appeared on the left side of my forehead.
Release 10 — day 42, dose 3
Symptoms: rash comes and goes (limited now to left side of forehead and both forearms), headaches, fatigue, increased heart rate during sleep (tracked by my watch)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hypotension | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
| SRO | Eye irritation | · | · | ✓ |
| SRO | Eye pain | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release